![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000047587 |
Receipt No. | R000054267 |
Scientific Title | Evaluation of the impact of the probiotics-containing dairy product on sleep quality |
Date of disclosure of the study information | 2022/05/09 |
Last modified on | 2022/04/25 |
Basic information | ||
Public title | Evaluation of the impact of the probiotics-containing dairy product on sleep quality | |
Acronym | Evaluation of the impact of the probiotics-containing dairy product on sleep quality | |
Scientific Title | Evaluation of the impact of the probiotics-containing dairy product on sleep quality | |
Scientific Title:Acronym | Evaluation of the impact of the probiotics-containing dairy product on sleep quality | |
Region |
|
Condition | ||
Condition | Healthy adults | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | Evaluation of the impact of the probiotics-containing dairy product on sleep quality. |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Subjective sleep feeling measured by the MA version of the OSA sleep inventory |
Key secondary outcomes | Sleep electroencephalography (EEG)
Mood questionnaire (VAS) Stress questionnaire (VAS) Pittsburgh Sleep Quality Index |
Base | |
Study type | Interventional |
Study design | |
Basic design | Parallel |
Randomization | Randomized |
Randomization unit | Individual |
Blinding | Double blind -all involved are blinded |
Control | Placebo |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 2 | |
Purpose of intervention | Prevention | |
Type of intervention |
|
|
Interventions/Control_1 | Dairy product containing probiotics
1 bottle (100 mL) /day for 8 weeks |
|
Interventions/Control_2 | Dairy product without probiotics
1 bottle (100 mL) /day for 8 weeks |
|
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | 1. Office worker
2. Subjects who are having sleep dissatisfaction 3. Subjects whose average sleep time on weekdays falls in 4 hours or more and 7 hours or less |
|||
Key exclusion criteria | 1. Subjects who have any clinically significant disease or allergies to foods and drugs which in the investigator's opinion could interfere with the safety of study participants or with the results of the study.
2. Subjects who are currently receiving drug treatment. 3. Subjects who are making an attempt to improve stress, sleep, and fatigue by taking functional foods or receiving therapies. 4. Subjects who are in living condition that can disturb their own sleep. 5. Subjects who have smoking habits. 6. Subjects who daily take excessive alcohol. 7. Subjects who have exercise habits during night time and are unable to finish an exercise by 2 hours before bedtime. 8. Subjects who work on irregular shifts or are engaged in physical labor. 9. Subjects whose sleeping environment is likely to change significantly during the study period due to a long trip or some others. 10. Subjects having skin diseases at where electrodes for EEG measurement are to be applied, or having potential that may cause skin disorders due to the application of the electrodes. 11. Subjects using pacemakers. 12. Females who are pregnant, intend to become pregnant, or breast-feeding. 13. Subjects who have a participation in another interventional clinical study within the last 4 weeks, or are intended to participate. 14. Subjects who have tested positive for SARS-CoV-2 within the last 4 weeks. 15. Others who have been considered ineligible for the participation in the study by the investigator. |
|||
Target sample size | 84 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Chiyoda Paramedical Care Clinic | ||||||
Division name | Doctor | ||||||
Zip code | 103-0021 | ||||||
Address | 2F Daiwa Bldg. 3-3-10, Nihonbashi Hongokucho, Chuo-ku, Tokyo, Japan | ||||||
TEL | 03-6225-9005 | ||||||
cpcc-contact@cpcc.co.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | CPCC Company Limited | ||||||
Division name | Clinical Planning Department | ||||||
Zip code | 103-0021 | ||||||
Address | 4F Daiwa Bldg. 3-3-10, Nihonbashi Hongokucho, Chuo-ku, Tokyo, Japan | ||||||
TEL | 03-6225-9001 | ||||||
Homepage URL | |||||||
m.n@cpcc.co.jp |
Sponsor | |
Institute | CPCC Company Limited |
Institute | |
Department |
Funding Source | |
Organization | Yakult Honsha Co., Ltd. |
Organization | |
Division | |
Category of Funding Organization | Profit organization |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Institutional Review Board of Chiyoda Paramedical Care Clinic |
Address | 2F Daiwa Bldg. 3-3-10, Nihonbashi Hongokucho, Chuo-ku, Tokyo, Japan |
Tel | 03-6225-9005 |
IRB@cpcc.co.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054267 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |